Derakhshan Behrad (CIK 1853109) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy EWTX (5,781 shares), Buy EWTX (7,500 shares), Sell EWTX (2,171 shares), Sell EWTX (304 shares), Sell EWTX (150 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Business Officer | Buy | 5,781 | $0 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Business Officer | Buy | 7,500 | $0 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Business Officer | Sell | 2,171 | $95,075 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Business Officer | Sell | 304 | $13,529 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Business Officer | Sell | 150 | $6,666 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Business Officer | Sell | 2,475 | $108,154 |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Business Officer | Buy | 5,781 | $0 |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | Chief Business Officer | Sell | 2,491 | $33,354 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | Chief Business Officer | Buy | 5,209 | $0 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | Chief Business Officer | Sell | 1,691 | $27,817 |
Source: SEC Form 4 filings · as of 2026-08-14